Page 5 - Pharma Stocks
GSK Pharma surges 11%, hits 52-week high on improved outlook
The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.
 "GSK Pharma surges 11%, hits 52-week high on improved outlook")
Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals
On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals
 "Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals")
Strides Pharma hits 52-week low, slumps 9% on weak Q2 results
The management said a muted sales performance accompanied with a drop in gross margins and relatively higher operating costs has led to a negative operating leverage in H1
 "Strides Pharma hits 52-week low, slumps 9% on weak Q2 results")
Pharma funds lag sectoral peers despite Covid tailwind as US market weighs
In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns
 "Pharma funds lag sectoral peers despite Covid tailwind as US market weighs")
Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%
Natco Pharma said that a US District Court has issued a decision in favour of Pharmacyclics (a subsidiary of AbbVie), the brand owner of Imbruvica in a PIV litigation involving the product..
 "Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%")
Aurobindo Pharma hits 52-week low, slips 25% in one month
The stock of the pharmaceutical company was trading at its lowest level since June 2020
 "Aurobindo Pharma hits 52-week low, slips 25% in one month")
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs
Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
 "Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs")
Natco Pharma slips 6% as Delhi HC allows injunction application by FMC Corp
The Hon'ble High Court of Delhi today orally pronounced judgment in the interim injunction application filed by FMC Corporation on CTPR
 "Natco Pharma slips 6% as Delhi HC allows injunction application by FMC Corp")
Markets log first gain in 5 days; financial, pharma stocks take charge
After a range-bound trading through the day, the BSE Sensex ended 166.07 points or 0.32 per cent higher at 52,484.67
 "Markets log first gain in 5 days; financial, pharma stocks take charge")
Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks
After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100
 "Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks")
Indian shares open flat as pharma boost offsets losses in tech stocks
Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks
 "Indian shares open flat as pharma boost offsets losses in tech stocks")
Sensex rebounds 359 points; financial, pharma stocks key drivers
The 30-share Sensex finished 358.83 points or 0.69 per cent higher at 52,300.47. Intra-day, the index swung between a high of 52,346.35 and a low of 51,957.92
 "Sensex rebounds 359 points; financial, pharma stocks key drivers")
After 100% gain since Nov, can the rally in Gland Pharma stock continue?
Gland's prospects remain strong, say analysts, as it has a robust pipeline of products with 50 pending Abbreviated New Drug Applications (ANDAs) and a healthy filing rate of 21 ANDAs in 9MFY21
Cipla dips 4% on lower than expected March quarter earnings
The company's performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter
 "Cipla dips 4% on lower than expected March quarter earnings")
Sensex, Nifty rise for 4th straight session; pharma, banking stocks gain
Over the last four sessions, the Sensex has gained 1,248.90 points or 2.58 per cent.
 "Sensex, Nifty rise for 4th straight session; pharma, banking stocks gain")
Laurus Labs shares advance 5% on strong growth outlook
Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model
 "Laurus Labs shares advance 5% on strong growth outlook")
Everest Kanto, Morepen Lab: 5 stocks to make your portfolio Covid-proof
Major stocks in the healthcare equipment sector are showing firm upside of over 15 per cent
 "Everest Kanto, Morepen Lab: 5 stocks to make your portfolio Covid-proof")
Fast-track Covid-19 vaccine approval gives indices a shot in the arm
Sensex, Nifty rise 1.4%; experts see volatility continuing in near term
 "Fast-track Covid-19 vaccine approval gives indices a shot in the arm")
The second wave: Pharma stocks make a comeback as Covid-19 cases rise
However, analysts say these stocks may not deliver bumper returns like last year
Orchid Pharma rises from ashes, expects to make profits in 12 months
Dhanuka Pharmaceuticals that took over the company almost a year ago, nursed it back to health from bankruptcy
 "Orchid Pharma rises from ashes, expects to make profits in 12 months")
